A retrospective study of the clinical features of new syphilis infections in an HIV-positive cohort in Alberta, Canada

Objectives Syphilis is a global health concern with an estimated 12 million infections occurring annually. Due to the increasing rates of new syphilis infections being reported in patients infected with HIV, and their higher risk for atypical and severe presentations, periodic screening has been recommended as a routine component of HIV care. We aimed to characterise incident syphilis presentation, serological features and treatment response in a well-defined, HIV-infected population over 11 years. Methods Since 2006, as routine practice of both the Southern Alberta Clinic and Calgary STI programmes, syphilis screening has accompanied HIV viral load measures every 4 months. All records of patients who, while in HIV care, either converted from being syphilis seronegative to a confirmed seropositive or were reinfected as evidenced by a fourfold increase in rapid plasma reagin (RPR) after past successful treatment, were reviewed. Results We identified 249 incident syphilis infections in 194 different individuals infected with HIV; 72% were initial infections whereas 28% were reinfections. Half (50.8%) of the infections were asymptomatic and identified only by routine screening. Symptomatic syphilis was more common when RPR titres were higher (p=0.03). In patients with recurrent syphilis infection, a trend was noted favouring symptomatic presentation (62%, p=0.07). All 10 patients with central nervous system (CNS) syphilis involvement presented with an RPR titre ≥1:32. Following syphilis infection, a decline of 42 cells/mm3 in CD4 (p=0.004) was found, but no significant changes in viral load occurred. No association was found with the stage of syphilis or symptoms at presentation and antiretroviral therapy use, CD4 count or virological suppression. Conclusion Routine screening of our HIV-infected population identified many asymptomatic syphilis infections. The interaction of HIV and syphilis infection appears to be bidirectional with effects noted on both HIV and syphilis clinical and serological markers.

[1]  M. Gill,et al.  Increasing incidence of syphilis among patients engaged in HIV care in Alberta, Canada: a retrospective clinic-based cohort study , 2018, BMC Infectious Diseases.

[2]  A. Trkola,et al.  High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 Infection , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  R. Peeling,et al.  Advancing prevention of sexually transmitted infections through point-of-care testing: target product profiles and landscape analysis , 2017, Sexually Transmitted Infections.

[4]  D. Glidden,et al.  Response to: A double-edged sword: does highly active antiretroviral therapy contribute to syphilis incidence by impairing immunity to Treponema pallidum? , 2017, Sexually Transmitted Infections.

[5]  Sang Woo Park,et al.  A double-edged sword: does highly active antiretroviral therapy contribute to syphilis incidence by impairing immunity to Treponema pallidum? , 2017, Sexually Transmitted Infections.

[6]  C. Marra,et al.  Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis. , 2016, The Journal of infectious diseases.

[7]  K. Workowski,et al.  Sexually transmitted diseases treatment guidelines, 2015. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[8]  H. Günthard,et al.  Increases in Condomless Sex in the Swiss HIV Cohort Study , 2015, Open forum infectious diseases.

[9]  K. Workowski,et al.  Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Rowley,et al.  Global incidence and prevalence of selected curable sexually transmitted infections: 2008 , 2012 .

[11]  Stuart Berman,et al.  Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[12]  W. Miller,et al.  Sexually transmitted infections among patients with acute HIV in North Carolina. , 2009, Sexually transmitted diseases.

[13]  J. V. D. van der Meer,et al.  High Incidence of Asymptomatic Syphilis in HIV-Infected MSM Justifies Routine Screening , 2009, Sexually Transmitted Diseases.

[14]  K. Riesenberg,et al.  Syphilis and HIV co-infection. , 2009, European journal of internal medicine.

[15]  Richard D Moore,et al.  Neurosyphilis in a clinical cohort of HIV-1-infected patients , 2008, AIDS.

[16]  J. Klausner,et al.  Syphilis and HIV infection: an update. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  E. Negredo,et al.  HIV and Syphilis: When to Perform a Lumbar Puncture , 2007, Sexually transmitted diseases.

[18]  J. Ena,et al.  Impact of Syphilis Infection on HIV Viral Load and CD4 Cell Counts in HIV-Infected Patients , 2007, Journal of acquired immune deficiency syndromes.

[19]  A. Copas,et al.  The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen , 2005, Sexually Transmitted Infections.

[20]  B. Azadian,et al.  Increasing detection of asymptomatic syphilis in HIV patients , 2005, Sexually Transmitted Infections.

[21]  Sam Ratnam,et al.  The laboratory diagnosis of syphilis. , 2005, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[22]  J. Klausner,et al.  Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections , 2004, AIDS.

[23]  S. Lightman,et al.  Syphilis and HIV: a dangerous combination. , 2004, The Lancet. Infectious diseases.

[24]  C. Marra,et al.  Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. , 2004, The Journal of infectious diseases.

[25]  J. Radolf,et al.  Clinical Manifestations of Early Syphilis by HIV Status and Gender: Results of the Syphilis and HIV Study , 2001, Sexually transmitted diseases.

[26]  C. Celum,et al.  The clinical manifestations and treatment of sexually transmitted diseases in human immunodeficiency virus-positive men. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  D. Fleming,et al.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. , 1999, Sexually transmitted infections.

[28]  Steven C. Johnson,et al.  A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. , 1997, The New England journal of medicine.

[29]  T. Quinn,et al.  Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. , 1992, The Journal of infectious diseases.